Reuters logo
BRIEF- Shanghai Pharmaceuticals Holding and unit receive approval for drug clinical trial
October 12, 2017 / 9:05 AM / 11 days ago

BRIEF- Shanghai Pharmaceuticals Holding and unit receive approval for drug clinical trial

Oct 12(Reuters) - Shanghai Pharmaceuticals Holding Co Ltd

* Says co and Shanghai-based wholly owned unit received approval for drug clinical trial for a kind of injection, which is mainly used for treatment of HER2-positive breast cancer, from China Food and Drug Administration

Source text in Chinese: goo.gl/BUpQna

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below